Editorial [Hot Topic:Preamble: CDC25 Phosphatases in Cancer and CDC25 Inhibitors (Guest Editor: Gregoire Pierre Prevost)]

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 8, 2008-12 ,pp. : 817-817

Bentham Science Publishers

Access to resources Recommend Favorite

Mutant B-Raf Kinase Inhibitors as Anticancer Agents

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 12, 2016-12 ,pp. : 1558-1575

Bentham Science Publishers

Access to resources Recommend Favorite

In Vivo Roles of CDC25 Phosphatases: Biological Insight into the Anti-Cancer Therapeutic Targets

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 8, 2008-12 ,pp. : 832-836

Bentham Science Publishers

Access to resources Recommend Favorite

Combination of Hedgehog inhibitors and standard anticancer agents synergistically prevent osteosarcoma growth

By                          

International Journal of Oncology, Vol. 48, Iss. 1, 2016-01 ,pp. : 235-242

Spandidos Publications

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors: A New Wave of Molecular Targeted Anticancer Agents

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 2, Iss. 2, 2007-06 ,pp. : 119-134

Bentham Science Publishers

Access to resources Recommend Favorite